Cremer, Anjali
Stegmaier, Kimberly
Funding for this research was provided by:
Deutsche Krebshilfe
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35 CA210030-01, 1P50 CA206963-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 12 November 2019
Revised: 6 December 2019
Accepted: 10 January 2020
First Online: 4 February 2020
Ethics approval and consent to participate
: N/A
: N/A
: N/A
: K.S. currently has funding from Novartis on topics unrelated to this manuscript and has consulted for Rigel Pharmaceuticals.
: K.S. is funded by National Cancer Institute R35 CA210030-01 and 1P50 CA206963-01. A.C was funded by Deutsche Krebshilfe.
Free to read: This content has been made available to all.